PolyPid Joins Consortium of EU's Seventh Framework Program to Develop Unique Treatment of Biofilm-Associated Infections
The project will explore antibacterial peptides entrapped with PolyPid technology and the controlled and sustained release of these peptides when used for coating of indwelling medical devices, to prevent and control biofilm-associated infections.
In addition to PolyPid, the BALI consortium comprises six companies and research organizations, including The Academic Medical Center of the University of Amsterdam, AO Research Institute, Leiden University Medical Center, AO Clinical Investigation and Documentation, Austrian Academy of Sciences, and Madam Therapeutics.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.